Enrique Poradosu
2023
In 2023, Enrique Poradosu earned a total compensation of $1.6M as Chief Scientific & Business Officer at Nuvectis Pharma, a 61% increase compared to previous year.
Compensation breakdown
Bonus | $250,750 |
---|---|
Salary | $454,750 |
Stock Awards | $857,900 |
Total | $1,563,400 |
Poradosu received $857.9K in stock awards, accounting for 55% of the total pay in 2023.
Poradosu also received $250.8K in bonus and $454.8K in salary.
Rankings
In 2023, Enrique Poradosu's compensation ranked 738th out of 2,785 executives tracked by ExecPay. In other words, Poradosu earned more than 73.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 738 | 74th |
Manufacturing | 429 | 72nd |
Chemicals And Allied Products | 294 | 66th |
Drugs | 288 | 65th |
Pharmaceutical Preparations | 190 | 68th |
Poradosu's colleagues
We found two more compensation records of executives who worked with Enrique Poradosu at Nuvectis Pharma in 2023.